InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by DAVIS STEPHEN, Chairman & CEO. Director active across 3 companies, notably Acadia Pharmaceuticals INC. Aggregated, 10 filings have been recorded. The latest transaction was filed on 23 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
15,625 shares
Common Stock
SEC:0001209191-22-026941:0·
010,945 shares0
Common Stock
SEC:0001209191-22-013273:0·
9,527 shares
Common Stock
SEC:0001209191-22-002748·
9,527 shares
Common Stock
SEC:0001209191-22-002748:0·
018,715 shares0
Common Stock
SEC:0001628280-22-000409·
018,715 shares0
Common Stock
SEC:0001628280-22-000409:0·
010,452 shares0
Common Stock
SEC:0001209191-21-071167·
010,452 shares0
Common Stock
SEC:0001209191-21-071167:0·
5,938 shares
Common Stock
SEC:0001209191-21-060957·
5,938 shares
Common Stock
SEC:0001209191-21-060957:0·
10 of 10 declarations
About DAVIS STEPHEN
Stephen Davis serves as CEO and Director of Acadia Pharmaceuticals Inc., Heron Therapeutics, Inc., and Bellicum Pharmaceuticals, Inc. In these roles, he is responsible for the strategic direction and management of the companies' operations. Stephen plays a key role in developing new therapies and optimizing the performance of these biopharmaceutical companies.
